• Budesonide

  • Ciclesonide

  • Fluticasone Propionate

  • Fluticasone Furoate

  • Mometasone Furoate (Anhydrous and Monohydrate)

  • Formoterol Fumarate Dihydrate (hemifumarate)

  • Salmeterol Xinafoate

  • Salbutamol Sulphate

  • Glycopyrronium Bromide

  • Indacaterol Maleate

  • Tiotropium Bromide

  • Tobramycin

  • Beclomethasone Dipropionate

API List

Licensing

Knightpoint is seeking licensing agreements to combine the Mirai inhaler design with customers’ specific drug and formulation requirements. These are combination products, and we realize the device and drug need to be developed and optimized together as a system. We offer device design, prototyping, formulation assistance, and GMP testing, and we can tailor the system performance to meet your needs. Please contact us to hear more about our capabilities.